Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses

Equine Veterinary Journal

Volumn 39, Issue 6, 2007, Pages 486-490

  Long, M T ^a   Gibbs, E P J ^a   Mellencamp, M W ^b   Zhang, S ^b   Barnett, D C ^b   Seino, K K ^a   Beachboard, S E ^a   Humphrey, P P ^a  

^a University of Florida   (United States)

^b Intervet Inc   (United States)

Author keywords

Horse; Live Flavivirus chimera; Safety; Vaccine; West Nile virus

Indexed keywords

EQUIDAE; FLAVIVIRUS; WEST NILE VIRUS;

LIVE VACCINE; VIRUS ANTIBODY; WEST NILE VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHIMERA; DISEASE TRANSMISSION; DOSE RESPONSE; FECES; FEMALE; HORSE; HORSE DISEASE; IMMUNOLOGY; MALE; PATHOGENICITY; SAFETY; TIME; VIROLOGY; VIRULENCE; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CHIMERA; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FECES; FEMALE; HORSE DISEASES; HORSES; MALE; SAFETY; TIME FACTORS; VACCINES, ATTENUATED; VIRULENCE; WEST NILE FEVER; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

EID: 38449084147     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516407X214473     Document Type: Article

References (22)

1. Anon (2003) Equine WNV Outlook for the United States. United States Department of Agriculture (USDA), Available at: http://www.aphis.usda. gov/vs/ceah/ncahs/nahms/equine/index.htm; Accessed 24th July, 2006.
2. Anon (2005) Center for Veterinary Biologics Notice no. 05-23. United States Department of Agriculture (USDA), Available at: http://www.aphis.usda.gov/vs/cvb/html/notices.html; Accessed 15th June, 2006.
3. Anon (2006a) West Nile Virus - Statistics, Surveillance, and Control; 2005 West Nile Virus Activity in the United States. Centres for Disease Control and Prevention, Available at: http://www.cdc.gov/ncidod/dvbid/westnile/ surv&controlCase Count05_detailed.htm; Accessed 24th July, 2006.
4. Anon (2006b) West Nile Virus in 2005 - States with an Equine Case(s). United States Department of Agriculture (USDA), Available at: http://www.aphis.usda.gov/vs/nahss/equine/wnv/index.htm; Accessed 24th July, 2006.
5. Arroyo, J., Miller, C.A., Catalan, J. and Monath, T.P. (2001) Yellow fever vector livevirus vaccines: West Nile virus vaccine development. Trends Mol. Med. 7, 350-354.
6. Arroyo, J., Miller, C., Catalan, J., Myers, G.A., Ratterree, M.S., Trent, D.W. and Monath, T.P. (2004) ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J. Virol. 78, 12497-12507.
7. Chambers, T.J., Nestorowicz, A., Mason, P.W. and Rice, C.M. (1999) Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J. Virol. 73, 3095-3101.
8. Davidson, A.H., Traub-Dargatz, J.L., Rodeheaver, R.M., Ostlund, E.N., Pedersen, D.D., Moorhead, R.G., Stricklin, J.B., Dewell, R.D., Roach, S.D., Long, R.E., Albers, S.J., Callan, R.J. and Salman, M.D. (2005) Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. vet. med. Ass. 226, 240-245.
9. Guirakhoo, F., Weltzin, R., Chambers, T.J., Zhang, Z.X., Soike, K., Ratterree, M., Arroyo, J., Georgakopoulos, K., Catalan, J. and Monath, T.P. (2000) Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J. Virol. 74, 5477-5485.
10. Hayes, C.G. (2001) West Nile virus: Uganda, 1937, to New York, 1999. Ann. N. Y. Acad. Sci. 951, 25-37.
11. Higgs, S., Vanlandingham, D.L., Klingler, K.A., McElroy, K.L., McGee, C.E., Harrington, L., Lang, J., Monath, T.P. and Guirakhoo, F. (2006) Growth characteristics of Chimerivax-Den vaccine virus in Aedes aegypti and Aedes albopictus from Thailand. Am. J. Trop. Med. Hyg. 75, 986-993.
12. Johnson, B.W., Chambers, T.V., Crabtree, M.B., Arroyo, J., Monath, T.P. and Miller, B.R. (2003) Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. Med. Vet. Entomol. 17, 235-243.
13. Jupp, P.G. (1974) Laboratory studies on the transmission of West Nile virus by Culex (Cx) univittatus Theobald; factors influencing the transmission rate. J. Med. Entomol. 11, 455-458.
14. Monath, T.P. (2001) Yellow fever: an update. Lancet infect. Dis. 1, 11-20.
15. Monath, T.P., Liu, J., Kanesa-Thasan, N., Myers, G.A., Nichols, R., Deary, A., McCarthy, K., Johnson, C., Ermak, T., Shin, S., Arroyo, J., Guirakhoo, F., Kennedy, J.S., Ennis, F.A., Green, S. and Bedford, P. (2006) A live, attenuated recombinant West Nile virus vaccine. Proc. Natl. Acad. Sci. USA. 103, 6694-6699.
16. Ostlund, E.N., Crom, R.L., Pedersen, D.D., Johnson, D.J., Williams, W.O. and Schmitt, B.J. (2001) Equine West Nile encephalitis, United States. Emerg. infect. Dis. 7, 665-669.
17. Petersen, L.R. and Roehrig, J.T. (2001) West Nile virus: a reemerging global pathogen. Emerg. infect. Dis. 7, 611-614.
18. Pletnev, A.G., Bray, M., Huggins, J. and Lai, C.J. (1992) Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc. Natl. Acad. Sci. USA. 89, 10532-10536.
19. Porter, M.B., Long, M.T., Getman, L.M., Giguere, S., MacKay, R.J., Lester, G.D., Alleman, A.R., Wamsley, H.L., Franklin, R.P., Jacks, S., Buergelt, C.D. and Detrisac, C.J. (2003) West Nile virus encephalomyelitis in horses: 46 cases (2001). J. Am. vet. med. Ass. 222, 1241-1247.
20. Reid, M., Mackenzie, D., Baron, A., Lehmann, N., Lowry, K., Aaskov, J., Guirakhoo, F. and Monath, T.P. (2006) Experimental infection of Culex annulirostris, Culex gelidu, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE). Am. J. Trop. Med. Hyg. 75, 659-663.
21. Rice, C.M., Grakoui, A., Galler, R. and Chambers, T.J. (1989) Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1, 285-296.
22. Salazar, P., Traub-Dargatz, J.L., Morley, P.S., Wilmot, D.D., Steffen, D.J., Cunningham, W.E. and Salman, M.D. (2004) Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J. Am. vet. med. Ass. 225, 267-274.